论文信息 - Phase 2 CAPTIVATE results of ibrutinib (ibr) plus venetoclax (ven) in first-line chronic lymphocytic leukemia (CLL). - 字舞流文

Phase 2 CAPTIVATE results of ibrutinib (ibr) plus venetoclax (ven) in first-line chronic lymphocytic leukemia (CLL).

I. Flinn | T. Kipps | J. Pagel | C. Tam | A. Tedeschi | W. Wierda | J. Dean | T. Siddiqi | P. Ghia | Cathy Zhou | K. Eckert | B. Kuss | J. Allan | X. Badoux | J. Ninomoto | D. James | E. G. Barca